Raab & Moskowitz Asset Management’s Quest Diagnostics DGX Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503K	Hold	2,371	–	–	0.1%	137
2026 Q1	$465K	Hold	2,371	–	–	0.1%	135
2025 Q4	$411K	Hold	2,371	–	–	0.09%	152
2025 Q3	$452K	Hold	2,371	–	–	0.1%	141
2025 Q2	$426K	Hold	2,371	–	–	0.1%	142
2025 Q1	$401K	Sell	2,371 -100	-4%	-$16.4K	0.1%	140
2024 Q4	$373K	Hold	2,471	–	–	0.09%	140
2024 Q3	$384K	Hold	2,471	–	–	0.1%	138
2024 Q2	$338K	Hold	2,471	–	–	0.09%	140
2024 Q1	$329K	Buy	+2,471	New	+$321K	0.09%	141
2020 Q1	–	Sell	-38	Closed	-$4K	–	223
2019 Q4	$4K	Buy	+38	New	+$3.96K	﹤0.01%	463
2018 Q4	–	Sell	-38	Closed	-$4K	–	234
2018 Q3	$4K	Buy	+38	New	+$4.17K	﹤0.01%	468

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Raab & Moskowitz Asset Management's DGX Position: Q2 2026 in Review

Raab & Moskowitz Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 2,371 shares worth $503K. The position accounts for 0.1% of the portfolio, ranked #137.

Raab & Moskowitz Asset Management first reported a position in DGX in Q3 2018 and has held it in 12 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Raab & Moskowitz Asset Management held 2,371 shares of Quest Diagnostics worth $503K as of Q2 2026.
Raab & Moskowitz Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.1% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #137 holding.
Raab & Moskowitz Asset Management first reported a position in Quest Diagnostics in Q3 2018 and has held it in 12 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.